Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $3.24M invested in Processa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$138K | |
| 2 | +$56.4K | |
| 3 | +$33K | |
| 4 |
VRM
Vectors Research Management
New York
|
+$11K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$6K |
Top Sellers
| 1 | -$69K | |
| 2 | -$4.84K | |
| 3 | -$3K | |
| 4 |
BlackRock
New York
|
-$1.3K |